Effect of Functional Beverage on Weight Control and Body Fat Mass in Overweight Women |
Chae, Jey-Sook
(Research Institute of Science for Aging, Yonsei University)
Lee, Jong-Ho (Department of Food & Nutrition, Yonsei University) Koh, Soo-Jeong (Department of Food & Nutrition, Yonsei University) Jang, Yong-Soo (Division of Cardiology, Cardiovascular Genome Center, Yonsei Medical Institute, Yonsei University) Lee, Jin-Hee (Nutraceuticals & Functional Foods Division, CJ Foods R & D, CJ Corp) |
1 | Badmaev, V. and Majeed, M. (1995). Open field, Physician controlled, clinical evaluation of botanical weight loss formula citrin. Presented at: Nutracon: Nutriceuticals, Dietary Supplementas and Functional Foods. Las Vegas, Nev. |
2 | Bray, G. A. and Greenway, F. L. (1999). Current and potential drugs for treatment of obesity. Endocr. Rev. 20, 805-75 DOI ScienceOn |
3 | Bremer, J. (1983). Camitine-metabolism and functions. Physiol. Rev. 63, 1420-80 |
4 | Chan, M. K., Persaud, J. W., Varghese, Z., Baillod, R. A. and Moorhead, J, P. (1982). Response patterns to DL-caruitine in patients on maintenance haemodialysis. Nephron. 30, 240-3 DOI |
5 | Field, A. E., Coakley, E. H., Must, A., Spadano, J. L., Laird, N., Dietz, W. H., Rimm, E. and Colditz, G. A. (2001), Impact of overweight on the risk of developing cominon chronic diseases during a lO-year period. Arch. Intern. Med. 161, 1581-6 DOI ScienceOn |
6 | Friedman, M., Byers, S. O., Rosenman, R. H. and Li, C. H. (1972). Hypocholesteroleimc effect of human growth hormone in coronary. Prone (type A) hypercholesterolemjc subjects. Proc. Soc. Exp. Biol. Med. 141, 76-80 DOI |
7 | Guamieri, G. F., Ranieri, F., Toigo, G., Vasile, A., Ciman, M., Rizzoli, V., Moracchiello, M. and Campanacci, L. (1980). Lipid-lowring effect of carnitine in chronically uremic patients treated with maintenance hemodialysis. Am. J. Clin. Nutr. 33, 1489-92 |
8 | Heymsfield, S. B., Allison, D. B., Vasselli, J. R., Pietrobelli, A., Greenfield, D., Nunez, C. (1998). Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial. JAMA. 280, 1596-600 DOI ScienceOn |
9 | Hoppel, C. L, and Genuth, S. M. (1980). Camitine metabolism in normal-weight and obese human subjects during fasting. Am. J. Physiol. 238, E409-15 |
10 | Jena, B. S., Jayaprakasha, G. K., Singh, R. P. and Sakariah, K. K. (2002). Chemistry and biochemistry of (-)-hydroxycitric acid from Garcinia. J. Agric. Food. Chem. 50, 10-22 DOI ScienceOn |
11 | Noel, P. H. and Pugh, J. A. (2002). Management of overweight and obese adults. BMJ. 325, 757-61 DOI ScienceOn |
12 | Perusse, L. and Bouchard, C. (1999). Genotype-environment interaction in hyman obesity. Nutr. Rev. 57, s31-s37 DOI ScienceOn |
13 | Shick, S. M., Wing, R. R., Klem, M. L., McGure, M. T., Hill, J. O. and Seagle, H. (2002). Persons successful at long-term weight loss and maintenance continue to consume a lowenergy, low-fat diet. J. Am. Diet. Assoc. 98, 408-13 DOI ScienceOn |
14 | Sullivan, A. C, Triscari, J., Hamilton, J. G., Miller, O. N. and Wheatley, V. R. (1974). Effect of (-)-hydroxycitrate upon the accumulation of lipid in the rat. I. Lipogenesis. Lipids. 9, 121-8 |
15 | Thom, E. (1996), Hydroxycitrate (HCA) in the treatment of obesity. Int. J. Obes. 20(supp1e 4), 48 |
16 | Triscan, J. and Sullivan, A. C. (1997). Comparative effects of (1)-hydroxycitraie and (+)-a11o-hydroxycitiate on acetyl CoA car boxylase and fatty acid and cholesterol synthesis in vivo. Lip-ids. 12, 357-63 |
17 | Crayhon, R. (1999). Camitine; Case histones. TotaI Health; Woodtand Hills. 21, 65-6 |
18 | Vacha, G. M., Giorcelli, G., D'lddio, S. and Corsi, M. (1985). Effect of long-term treatment with L-camitine on the lipid pat-tern of patients undergoing heamodialysis. Proc. Eur. Dial. transplant. Assoc. 22, 121-6 |
19 | Clouatre, D. and Rosenbaum, M. (1994). The diet and health benefits of HCA (Hydroxycitric acid); Keats Publishing, New Cannan, CT. |
20 | Conte, A. A. (1993). A non-prescription alternative on weight reduction therapy. Am. J. Bariatr. Med. Summer, 17-9 |
21 | Elisaf, M., Bairaktari, E., Katopodis, K., Pappas, M., Sferopoulos, G., Tzallas, C., Tsolas, O. and Siamopoulos, K. C. (1998). Effect of L-camitine supplementation on lipid parameters in hemodialysis patients. Am. J. Nephrol. 18, 416-21 DOI ScienceOn |
22 | Klauer, J. and Aronne, L. J. (2002). Managing overweight and obesity in women. Clin. Obstel. Gynecol. 45, 1080-8 DOI ScienceOn |
23 | Muramatsu, S., Yamazaki, S. and Hattori, Y. (1994). Effect of soy-peptine intake for long term xercise perforimances of Judo atheletes. Chiba. J. Physiol. Educat. 18, 41-8 |
24 | Lowenstein, J. M. (1971). Effect of (-)-hydroxycitrate on fatly acid synthesis by rat liver in vivo. J. Biol Chem. 246, 629-32 |
25 | Ministry of Health and Social Affirs. (1990). National Survey Report. |
26 | Ministry of Health and Social Affirs. (2000). National Survey Report |
27 | Weschler, A., Aviram, M., Levin, M., Better, O. S. and Birook, J. G. (1984). High dose of L-camitine increases platelet aggregation and plasma tnglyceride levels in uremic patients on hemodialysis. Nephron. 38, 120-4 DOI |
28 | Villani, R. G., Gannon, J., Self, M. and Rich, P. A. (2000). L-Car-nitine supplementauon combined with aerobic training does not promote weight loss in moderately obese women, Int. J. Sport. Nutr. Exerc. Metab. 10, 199-207 |
29 | Wanner, C, Wieland, H., Wackerle, B., Boeckle, H., Schollmeyer, P. and Horl, W. H. (1989). Ketogenic and antiketogenic effects of L-carnitine in hemodialysis patients. Kidney. Int. Suppt. 27, S264-8 |